Myoepithelial tumor
MONDO:0002380A benign or malignant tumor characterized by the presence of cells that show myoepithelial differentiation. Based on its morphologic features, it is classified as benign or malignant. A representative example of benign myoepithelioma is benign salivary gland myoepithelioma. Representative examples of malignant myoepithelioma or myoepithelial carcinoma are malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.
Also known as: myoepithelial neoplasm, myoepithelial tumor, myoepithelioma, benign myoepithelioma
1431 clinical trials for this condition and its sub-types, 2 tagged with Myoepithelial tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Myoepithelial tumor
-
Malignant myoepithelioma 2 trials
1 sub-type
- Malignant breast myoepithelioma 0 trials
-
Carcinoma ex pleomorphic adenoma 1 trial
2 sub-types
-
Breast myoepithelial tumor 0 trials
3 sub-types
- Breast adenomyoepithelioma 0 trials Sub-types →
- Breast myoepitheliosis 0 trials Sub-types →
- Malignant breast myoepithelioma 0 trials
-
Parachordoma 0 trials
1 sub-type
- Chest wall parachordoma 0 trials
Most studied deeper sub-types
-
New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return
Disease control Recruiting nowThis study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New stem cell approach aims to fight tough childhood cancers
Disease control Recruiting nowThis study tests a special stem cell transplant for children, teens, and young adults (ages 6 months to 25 years) with solid tumors that have come back or not responded to treatment. The transplant uses cells from a donor, with certain immune cells removed to reduce side effects,…
Phase 1/2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC